LGND Cash & Equivalents
Ligand Pharmaceuticals Inc · Cash & Equivalents
LGND Cash & Equivalents
Latest reported$174.93Mperiod ending
LGND FY Cash & Equivalents ($7.60M → $174.93M)
Annual Cash & Equivalents
High-resolution chart · PNG
LGND cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 174,927,000 | |
| 72,307,000 | |
| 22,954,000 | |
| 45,006,000 | |
| 19,522,000 | |
| 47,619,000 | |
| 71,543,000 | |
| 718,381,000 | |
| 201,661,000 | |
| 141,048,000 | |
| 200,219,000 | |
| 167,336,000 | |
| 15,979,000 | |
| 12,381,000 | |
| 7,041,000 | |
| 3,346,000 | |
| 16,032,000 | |
| 28,753,000 | |
| 76,812,000 | |
| 158,401,000 | |
| 66,756,000 | |
| 92,310,000 | |
| 59,030,000 | |
| 42,423,000 | |
| 20,741,000 | |
| 9,224,000 | |
| 29,900,000 | |
| 32,800,000 | |
| 62,300,000 | |
| 34,800,000 | |
| 16,000,000 | |
| 7,600,000 |